2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Starremans, P. G.J.F. Articles by Bindels, R. J.M. Search for Related Content PubMed PubMed Citation Articles by Starremans, P. G.J.F. Articles by Bindels, R. J.M.

Mutations in the Human Na-K-2Cl Cotransporter (NKCC2) Identified in Bartter Syndrome Type I Consistently Result in Nonfunctional Transporters

Patrick G.J.F. Starremans^*, Ferry F.J. Kersten^*, Nine V.A.M. Knoers, Lambertus P.W.J. van den Heuvel and René J.M. Bindels^*

Departments of *Cell Physiology, Human Genetics, and Pediatrics, University Medical Centre Nijmegen, The Netherlands.

Correspondence to Dr. René J.M. Bindels, 160 Cell Physiology, University Medical Centre Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31-24-3614211; Fax 31-24-3616413;

ABSTRACT. Bartter syndrome (BS) is a heterogeneous renal tubular disorder affecting Na-K-Cl reabsorption in the thick ascending limb of Henle’s loop. BS type I patients typically present with profound hypokalemia and metabolic alkalosis. The main goal of the present study was to elucidate the functional implications of six homozygous mutations (G193R, A267S, G319R, A508T, del526N, and Y998X) in the bumetanide-sensitive Na-K-2Cl cotransporter (hNKCC2) identified in patients diagnosed with BS type I. To this end, capped RNA (cRNA) of FLAG-tagged hNKCC2 and the corresponding mutants was injected in Xenopus laevis oocytes and transporter activity was measured after 72 h by means of a bumetanide-sensitive ²²Na⁺ uptake assay at 30°C. Injection of 25 ng of hNKCC2 cRNA resulted in bumetanide-sensitive ²²Na⁺ uptake of 2.5 ± 0.5 nmol/oocyte per 30 min. Injection of 25 ng of mutant cRNA yielded no significant bumetanide-sensitive ²²Na⁺ uptake. Expression of wild-type and mutant transporters was confirmed by immunoblotting, showing significantly less mutant protein compared with wild-type at the same cRNA injection levels. However, when the wild-type cRNA injection level was reduced to obtain a protein expression level equal to that of the mutants, the wild-type still exhibited a significant bumetanide-sensitive ²²Na⁺ uptake. Immunocytochemical analysis showed immunopositive staining of hNKCC2 at the plasma membrane for wild-type and all studied mutants. In conclusion, mutations in hNKCC2 identified in type I BS patients, when expressed in Xenopus oocytes, result in a low expression of normally routed but functionally impaired transporters. These results are in line with the hypothesis that the mutations in hNKCC2 are the underlying cause of the clinical abnormalities seen in patients with type I BS. E-mail: r.bindels@ncmls.kun.nl

This article has been cited by other articles:

				K. Brochard, O. Boyer, A. Blanchard, C. Loirat, P. Niaudet, M.-A. Macher, G. Deschenes, A. Bensman, S. Decramer, P. Cochat, et al. Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome Nephrol. Dial. Transplant., December 18, 2008; (2008) gfn689v1. [Abstract] [Full Text] [PDF]

				E. Riveira-Munoz, Q. Chang, N. Godefroid, J. G. Hoenderop, R. J. Bindels, K. Dahan, O. Devuyst, and for the Belgian Network for the Study of Gitelman Transcriptional and Functional Analyses of SLC12A3 Mutations: New Clues for the Pathogenesis of Gitelman Syndrome J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1271 - 1283. [Abstract] [Full Text] [PDF]

				C. A. Pressler, J. Heinzinger, N. Jeck, P. Waldegger, U. Pechmann, S. Reinalter, M. Konrad, R. Beetz, H. W. Seyberth, and S. Waldegger Late-Onset Manifestation of Antenatal Bartter Syndrome as a Result of Residual Function of the Mutated Renal Na+-K+-2Cl- Co-Transporter J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2136 - 2142. [Abstract] [Full Text] [PDF]

				A. Paredes, C. Plata, M. Rivera, E. Moreno, N. Vazquez, R. Munoz-Clares, S. C. Hebert, and G. Gamba Activity of the renal Na+-K+-2Cl- cotransporter is reduced by mutagenesis of N-glycosylation sites: role for protein surface charge in Cl- transport Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1094 - F1102. [Abstract] [Full Text] [PDF]

				R. Juncos, N. J. Hong, and J. L. Garvin Differential effects of superoxide on luminal and basolateral Na+/H+ exchange in the thick ascending limb Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R79 - R83. [Abstract] [Full Text] [PDF]

				G. Gamba Molecular Physiology and Pathophysiology of Electroneutral Cation-Chloride Cotransporters Physiol Rev, April 1, 2005; 85(2): 423 - 493. [Abstract] [Full Text] [PDF]

				E. Sabath, P. Meade, J. Berkman, P. d. l. Heros, E. Moreno, N. A. Bobadilla, N. Vazquez, D. H. Ellison, and G. Gamba Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease Am J Physiol Renal Physiol, August 1, 2004; 287(2): F195 - F203. [Abstract] [Full Text] [PDF]

				P. G.J.F. Starremans, F. F.J. Kersten, L. P.W.J. van den Heuvel, N. V.A.M. Knoers, and R. J.M. Bindels Dimeric Architecture of the Human Bumetanide-Sensitive Na-K-Cl Co-transporter J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3039 - 3046. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673